Teleflex Incorporated (NYSE:TFX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lessened its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 61.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,179 shares of the medical technology company's stock after selling 13,110 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Teleflex were worth $1,130,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB increased its holdings in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after buying an additional 100 shares during the last quarter. Headlands Technologies LLC acquired a new position in Teleflex during the fourth quarter worth $29,000. Whipplewood Advisors LLC lifted its holdings in Teleflex by 7,700.0% in the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after acquiring an additional 231 shares during the period. Allworth Financial LP boosted its stake in shares of Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after acquiring an additional 212 shares in the last quarter. Finally, True Wealth Design LLC grew its holdings in shares of Teleflex by 62.3% in the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after acquiring an additional 104 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 2.2%

NYSE TFX traded down $2.55 on Wednesday, reaching $112.30. The company had a trading volume of 530,397 shares, compared to its average volume of 808,068. The firm has a 50-day moving average of $118.48 and a 200-day moving average of $135.98. Teleflex Incorporated has a 1 year low of $108.90 and a 1 year high of $249.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. The firm has a market capitalization of $4.96 billion, a PE ratio of 26.42, a P/E/G ratio of 1.72 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%. The company had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. During the same period last year, the firm earned $3.42 earnings per share. The company's revenue was up 4.2% on a year-over-year basis. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, August 15th. Teleflex's payout ratio is 32.00%.

Analyst Upgrades and Downgrades

TFX has been the subject of several recent research reports. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday. Morgan Stanley decreased their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Mizuho raised their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Truist Financial dropped their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Finally, Royal Bank Of Canada lifted their price target on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a report on Friday, August 1st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Teleflex currently has a consensus rating of "Hold" and a consensus target price of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.